🔍
Search Results - patrick+ross
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
High Affinity Beta Lactamase Inhibitors
C11674: Novel Beta-Lactamase InhibitorsNovelty: This technology comprises of a series of compounds based on a novel scaffold that selectively inhibits the enzyme, beta lactamase with high affinity thereby providing a potential solution to beta-lactam resistance in bacteria.Value Proposition: Development of resistance to currently available beta-lactam...
Published: 3/13/2025
|
Inventor(s):
Ernesto Freire
,
Rogelio Siles
,
Patrick Ross
Keywords(s):
Antagonists/Inhibitors
,
Antibiotic
,
Bacterial Infections
,
Disease Indication
,
Infectious Diseases
,
Novel
,
Predicted Novelty
,
Single
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Infectious Diseases
,
Clinical and Disease Specializations > Infectious Diseases > Bacterial Infections
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Small Molecules
High Affinity Chymase Inhibitors
C11636: Novel Chymase Inhibitors for Treatment of AtherosclerosisNovelty: This technology comprises of a series of compounds based on a novel scaffold allowing for selective inhibition of chymase, an enzyme implicated in the development of atheroscleriosis.Value Proposition: Activation of the enzyme chymase, a serine protease sets off a cascade of events...
Published: 3/13/2025
|
Inventor(s):
Rogelio Siles
,
Patrick Ross
,
Ernesto Freire
Keywords(s):
Antagonists/Inhibitors
,
Biomarker
,
Cardiovascular Diseases
,
Disease Indication
,
Mechanism-of-action Biomarker
,
Novel
,
Predicted Novelty
,
Small Molecules
,
Target
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Cardiovascular
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Technology Classifications > Therapeutic Modalities > Targets
,
Technology Classifications > Diagnostics
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Cardiovascular > Atherosclerosis
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum